Scientists are looking at the possibility of new treatment protocols for Multiple Sclerosis, after new findings in recent studies of the disease.
What causes the disease?
Multiple sclerosis (MS) is a relatively rare disease that causes the immune system to attack the protective covering of nerves, with the resulting nerve damage disrupting communication between the brain and the body. There have been efforts to properly understand its cause, including studies that pointed to certain gene variations and environmental factors. Also high on the suspect list is a common virus called Epstein-Barr virus.
What are the symptoms?
While their severity and duration may vary from person to person, MS symptoms include vision loss, pain, fatigue, and impaired physical coordination. While the Epstein-Barr virus is common, infecting about 90% of the world’s population, MS is a relatively rare disease that is said to be affecting about 3 million people globally. Currently, its treatment includes physiotherapy and medications that suppress the immune system.
What are the latest findings?
Discovered in 1964, the virus is said to easily spread, especially through saliva. Recent studies have reported that the disease is triggered when the central nervous system is impacted by the immune system’s response to the virus’s attack. The latest findings have now raised hope for new treatment measures, including vaccines – encouraging news for patients, as the disease is reported to have defied current treatment protocols in some patients. People who have had the disease are said to have a possibility of developing other ailments, including cancer.